Home > Insider Trading > Filing (0000899243-19-027012)

Filing Details

Accession Number:: 0000899243-19-027012
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-11-08 18:56:56
Reporting Period:: 2019-11-06

Accepted Time:: 2019-11-08 18:56:56
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
861838	Idera Pharmaceuticals Inc.	IDRA	Biological Products, (No Disgnostic Substances) (2836)	043072298

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1193366	El Youssef Zein	Pillar Invest Offshore Sal, Starco Ctr, Bloc B, 3Rd Floor, Omar Daouk Street Beirut M8 2020-3313	No	No	Yes	No
1534425	Pillar Pharmaceuticals I Lp	Pillar Invest Offshore Sal Starco Ctr, Bloc B, 3Rd Floor, Omar Daouk Street Beirut M8 2020-3313	No	No	Yes	No
1534428	Pillar Invest Corp	Pillar Invest Offshore Sal Starco Ctr, Bloc B, 3Rd Floor, Omar Daouk Street Beirut M8 2020-3313	No	No	Yes	No
1562069	Pillar Pharmaceuticals Ii, L.p.	Pillar Invest Offshore Sal, Starco Ctr, Bloc B, 3Rd Floor, Omar Daouk Street Beirut M8 2020-3313	No	No	Yes	No
1576891	Pillar Pharmaceuticals Iii, L.p.	Pillar Invest Offshore Sal Starco Ctr, Bloc B, 3Rd Floor Omar Daouk Street Beirut M8 2020-3313	No	No	Yes	No
1588130	Pillar Pharmaceuticals Iv, L.p.	Pillar Invest Offshore Sal Starco Ctr, Bloc B, 3Rd Floor, Omar Daouk Street Beirut M8 2020-3313	No	No	Yes	No
1687312	Pillar Pharmaceuticals V Lp	Pillar Invest Offshore Sal Starco Ctr, Bloc B, 3Rd Floor, Omar Daouk Street Beirut M8 2020-3313	No	No	Yes	No
1783582	Abude Umari	Pillar Invest Offshore Sal Starco Ctr, Bloc B, 3Rd Floor, Omar Daouk Street Beirut M8 2020-3313	No	No	Yes	No
1783583	Pillar Partners Foundation, L.p.	Pillar Invest Offshore Sal Starco Ctr Bloc B, 3Rd Floor, Omar Daouk Street Beirut M8 2020-3313	No	No	Yes	No
1783584	Pillar Pharmaceuticals 6, L.p.	Pillar Invest Offshore Sal Starco Ctr, Bloc B, 3Rd Floor, Omar Daouk Street Beirut M8 2020-3313	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2019-11-06	100,000	$2.50	3,318,224	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2019-11-07	10,000	$2.45	3,308,224	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2019-11-08	9,000	$2.44	3,299,224	No	4	S	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote

Footnotes

The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $2.4557-$2.5000. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
Shares sold by Pillar Pharmaceuticals I, L.P. ("Pillar I"). Pillar Invest Corporation ("Pillar GP") disclaims Section 16 beneficial ownership of the securities beneficially owned by Pillar I and this report shall not be deemed an admission that Pillar GP is the Section 16 beneficial owner of any such securities, except to the extent of its pecuniary interest therein, if any, by virtue of its ownership interest in Pillar I. Following the transactions on 11/6/2019 and 11/7/2019, Pillar I owns directly 36,100 shares of common stock of the Issuer.
Shares sold by Pillar Pharmaceuticals II, L.P. ("Pillar II"). Pillar GP disclaims Section 16 beneficial ownership of the securities beneficially owned by Pillar II and this report shall not be deemed an admission that Pillar GP is the Section 16 beneficial owner of any such securities, except to the extent of its pecuniary interest therein, if any, by virtue of its ownership interest in Pillar II. Following this transaction, Pillar II owns directly 30,820 shares of common stock of the Issuer.
Shares sold by Pillar Pharmaceuticals III, L.P. ("Pillar III"). Pillar GP disclaims Section 16 beneficial ownership of the securities beneficially owned by Pillar III and this report shall not be deemed an admission that Pillar GP is the Section 16 beneficial owner of any such securities, except to the extent of its pecuniary interest therein, if any, by virtue of its ownership interest in Pillar III. Following this transaction, Pillar III owns directly 39,780 shares of common stock of the Issuer.
Shares sold by Pillar Pharmaceuticals IV, L.P. ("Pillar IV"). Pillar GP disclaims Section 16 beneficial ownership of the securities beneficially owned by Pillar IV and this report shall not be deemed an admission that Pillar GP is the Section 16 beneficial owner of any such securities, except to the extent of its pecuniary interest therein, if any, by virtue of its ownership interest in Pillar IV. Following this transaction, Pillar IV owns directly 1,000 shares of common stock of the Issuer.
Shares sold by Pillar Pharmaceuticals V, L.P. ("Pillar V"). Pillar GP disclaims Section 16 beneficial ownership of the securities beneficially owned by Pillar V and this report shall not be deemed an admission that Pillar GP is the Section 16 beneficial owner of any such securities, except to the extent of its pecuniary interest therein, if any, by virtue of its ownership interest in Pillar V. Following this transaction, Pillar V owns directly 35,000 shares of common stock of the Issuer.